| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 172,715 | 152,420 | 134,159 | 184,724 | | Cost of Revenue | 114,666 | 142,454 | 126,421 | 207,569 | | | Gross Profit | 58,049 | 9,966 | 7,738 | (22,845) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 48,152 | 5,323 | 4,693 | (32,252) | | Non Recurring |
-
|
-
|
-
| 4,644 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,897 | 4,643 | 3,045 | 4,763 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 9,897 | 4,643 | 3,045 | 4,763 | | Interest Expense | 1,098 | 1,305 | 1,501 | 1,355 | | Income Before Tax | 8,799 | 3,338 | 1,544 | 3,408 | | Income Tax Expense | 3,801 | 1,437 | 790 | 1,446 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,998 | 1,901 | 754 | 1,962 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,998 | 1,901 | 754 | 1,962 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,998 | $1,901 | $754 | $1,962 |
|
1.08% Nasdaq 
Income Statement
